^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Soft Tissue Sarcoma |
| Drug: | ifosfamide (Bifunctional alkylating agent) + pegylated liposomal doxorubicin (Topoisomerase II inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Excerpt:
Summary of recommendations...Management of advanced/metastatic, clinically unresectable STS...Doxorubicin + ifosfamide [I, B].
DOI:
10.1093/annonc/mdy310
